Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

AUSCANN GROUP HOLDINGS LTD

(AC8)
SynthèseGraphiquesActualitésAgendaSociétéFinancesFondsCommunauté 
SynthèseToute l'actualitéAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur AUSCANN GROUP HOLDINGS LTD
15/11Auscann Group Holdings Ltd Announces Board Changes
15/11AUSCANN : Annual General Meeting - CEO Presentation
12/11Auscann Group to Start Cannabinoid Trial for Spinal Cord Injury; Shares Surge 11%
11/11Auscann Group Holdings Limited to Commence Cannabinoid Trial in Spinal Cord Injury
18/10AUSCANN : Files Formal Meeting Request with US FDA Related to Veterinary Drug
13/10AUSCANN : Completes Dose Tolerance Study, Files Registrations for Veterinary Product
13/10AusCann Group Holdings Ltd Completes US Safety Study for Dermacann Registration
21/09AUSCANN : Appoints Data, Asset Reviewer to Accelerate Development of Cannabinoid-based Dru..
09/09Auscann Group Taps US Consultant to Advance Cannabis Drug Candidate in US
30/08Auscann Group Holdings Ltd Reports Earnings Results for the Full Year Ended June 30, 20..
20/07AUSCANN : Starts Australian Product Registration for Anti-Inflammatory Product for Dog Ski..
20/07AusCann Group Holdings Limited Commences Australian Product Registration for Dogs
01/07Auscann Secures Medical Cannabis Supply Deal with Tasmanian Department of Health
17/06AUSCANN : Leases R&D Facility for Initial Five-Year Term
17/06AusCann Group Holdings Limited Enters into Lease Agreement for R&D Facility
30/04AusCann Group Holdings Ltd Updates the Market on Key Clinical Veterinary and Owner Scor..
23/04AUSCANN : Receives Over $1 Million in Research and Development Tax Rebate
01/04Auscann Group Holdings Ltd Appoints Geoffrey Starr as Director
22/03AUSCANN : Finalizes Sale of 50% Stake in Chilean JV
11/03AusCann Group Holdings Ltd completed the acquisition of CannPal Animal Therapeutics Lim..
25/02Auscann Group Holdings Ltd Reports Earnings Results for the Half Year Ended December 31..
22/02Auscann Group Holdings Ltd Appoints Charles Altshuler as Chief Financial Officer, Effec..
22/02AusCann Group Holdings Limited Announces Executive Changes
12/02AUSCANN : Completes Small Shareholding Sale Facility
08/01AusCann Group Holding Announces Management Changes
08/01AUSCANN : CannPal Managing Director to Lead Merged Company Formed With AusCann; CannPal Ri..
2020AusCann Supports UN Reclassification of Cannabis-Derived Substances; Shares Drop 9%
2020AUSCANN GROUP HOLDINGS LTD (ASX : AC8) and CannPal Enter Into Scheme of Arrangement
2020AUSCANN GROUP HOLDINGS LTD (ASX : AC8) and CannPal Enter Into Scheme of Arrangement
2020AusCann Group Holdings Ltd entered into a scheme implementation deed to acquire CannPal..
2020AUSCANN : Selling 50% Stake in Chilean JV DayaCann; Shares Down 4%
2020Fundación Daya entered into an agreement to acquire remaining 50% stake in DayaCann SpA..
2020AusCann Group Holdings Limited Establishes Medical Advisory Board of Leading Clinicians..
2020AusCann Group Holdings Ltd Announces Resignation of Quentin Megson as CFO
2020AUSCANN GROUP HOLDINGS LTD(ASX : AC8) dropped from S&P/ASX Emerging Companies Index
2020AUSCANN GROUP HOLDINGS LTD(ASX : AC8) dropped from S&P Global BMI Index
2020AusCann Group Holdings Ltd Announces Resignation of Marcel Bonn-Miller as Non-Executive..
2020AusCann Group Holdings Ltd Completes Successfully Neuvis Capsule Phase I Study
2020Auscann Group Holdings Ltd Reports Earnings Results for the Full Year Ended June 30, 20..
2020AusCann Group Holdings Ltd Appoints Nick Woolf as Chief Executive Officer
2020AUSCANN GROUP HOLDINGS LTD(ASX : AC8) dropped from S&P/ASX All Ordinaries Index
2020AusCann Announces Resignation of Ido Kanyon as Chief Executive Officer
2020AusCann Group Holdings Ltd Completes Clinical Evaluation Recruitment and Commences Subj..
2020AusCann Group Holdings Limited Announces Change of Registered Office
2020AusCann to Commence Clinical Trial and Product Distribution
2020AusCann Group Holdings Limited Announces Executive Changes
2020Auscann Group Holdings Ltd Reports Earnings Results for the Half Year Ended December 31..
2020AusCann Group Holdings Limited Enters Exclusive Distribution Agreement with Clifford Ha..
2020AusCann Group Holdings Limited Completes the Manufacturing and Testing of its Proprieta..
2020Auscann Group Holdings Ltd Ceases Cheryl Edwardes Am as Director
2019AusCann Group Holdings Limited Announces New Chairman and Independent Director Appointm..
2019AusCann Group Holdings Limited Releases Hard-Shell Capsules to Clinical Evaluation
2019AUSCANN : Pharmaceutical Packaging Agreement with Aspen Pharmacare
2019AusCann Group Holdings Ltd Announces the Cessation of Paul MacLeman as Director
2019AusCann Group Holdings Ltd Announces Board Changes
2019AusCann Group Holdings Ltd Announces the Cessation of Malcolm James Washer as Director
2019AusCann Group Holdings Limited Announced Board Changes
2019Marcel Bonn-Miller Replaces Bruce Linton as Non-Executive Director of Auscann Group Hol..
2019Auscann Group Holdings Ltd Reports Earnings Results for the Full Year Ended June 30, 20..
2019AusCann Group Holdings Ltd Announces Executive Changes
2019AUSCANN GROUP HOLDINGS LTD(ASX : AC8) added to S&P/ASX All Ordinaries Index
2019Auscann Group Holdings Ltd. Reports Earnings Results for the Half Year Ended December 3..
2019Auscann Group Holdings Limited Announces Executive Changes, Effective May 22, 2019
2019AusCann Group Holdings Ltd Signs Cannabis Resin Supply Agreement with Canadian Mediphar..
2019Auscann Group Holdings Ltd Appoints Quentin Megson as Joint Company Secretary
2019AusCann Group Holdings Limited Establishes Research and Development Facility
2018AUSCANN : Leadership Transition Update
2018Auscann Group Holdings Ltd Appoints Paul Macleman as Interim CEO from 1 January 2019
2018AUSCANN : Results of Annual General Meeting
2018AUSCANN : AC8 Moves First Products to Commercial Manufacturing Site
2018AusCann Group Holdings Limited Appoints PCI Pharma to Manufacture its First Medicinal C..
2018AUSCANN : September 2018 Quarterly Activities and Cashflow Report
2018AUSCANN : Annual Report
2018AUSCANN : Notice of Annual General Meeting/Proxy Form
2018AUSCANN : Releases Cannabinoid Medical Education Resources
1  2  3Suiv.
Prochain événement sur AUSCANN GROUP HOLDINGS LTD